US FDA Lowers Bar for Latest COVID Monoclonal Antibody Authorization

gymnastic bar
Lilly's new COVID-19 mab got authorized with less clinical evidence than similar mabs • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America